Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 254

2.

Health education to school children in Okpatu, Nigeria: impact on onchocerciasis-related knowledge.

Shu EN, Okonkwo PO, Onwujekwe EO.

Public Health. 1999 Sep;113(5):215-8.

PMID:
10557114
3.

Maintaining compliance to ivermectin in communities in two West African countries.

Whitworth JA, Alexander ND, Seed P, Thomas W, Abiose A, Jones BR.

Health Policy Plan. 1996 Sep;11(3):299-307.

PMID:
10160375
4.

Onchocerciasis control in Nigeria: will households be able to afford community-directed treatment with ivermectin?

Onwujekwe O, Shu E, Onwuameze O, Ndum C, Okonkwo P.

Acta Trop. 2001 Dec 21;80(3):277-81.

PMID:
11700186
5.

Influence of health education on community participation in rapid assessment of onchocerciasis prior to distribution of ivermectin.

Shu EN, Nwadike KI, Onwujekwe EO, Ugwu OC, Okonkwo PO.

East Afr Med J. 1999 Jun;76(6):320-3.

PMID:
10750518
6.

The community-based treatment of onchocerciasis in Shao, Kwara State, Nigeria.

Oyibo WA, Fagenro-Beyioku AF.

Southeast Asian J Trop Med Public Health. 2002 Sep;33(3):496-503.

PMID:
12693582
7.

Predictors of compliance with community-directed ivermectin treatment in Uganda: quantitative results.

Nuwaha F, Okware J, Ndyomugyenyi R.

Trop Med Int Health. 2005 Jul;10(7):659-67.

8.

Additional health and development activities for community-directed distributors of ivermectin: threat or opportunity for onchocerciasis control?

Okeibunor JC, Ogungbemi MK, Sama M, Gbeleou SC, Oyene U, Remme JH.

Trop Med Int Health. 2004 Aug;9(8):887-96.

9.

Willingness to pay for community-based ivermectin distribution: a study of three onchocerciasis-endemic communities in Nigeria.

Onwujekwe OE, Shu EN, Nwagbo D, Akpala CO, Okonkwo PO.

Trop Med Int Health. 1998 Oct;3(10):802-8.

10.
11.
12.

[The strategic role of information, education and communication in treatment programs using ivermectin (Mectizan) under community directives].

Mohamed S, Dormant A, Nyiama T, Kassalow J, Laursen K, Baker SK, Boubacar IC.

Sante. 1998 Jan-Feb;8(1):79-80. French. No abstract available.

13.
14.

Adverse reactions from community directed treatment with ivermectin (CDTI) for onchocerciasis and loiasis in Ondo State, Nigeria.

Otubanjo OA, Adeoye GO, Ibidapo CA, Akinsanya B, Okeke P, Atalabi T, Adejai ET, Braide E.

Rev Biol Trop. 2008 Dec;56(4):1635-43.

PMID:
19419072
15.

Intention to continue with ivermectin treatment for onchocerciasis control after eight years of annual distribution in Cameroon, Nigeria, and Uganda.

Okeibunor JC, Brieger WR, Abiose AO, Elhassan E, Ndyomugyenyi R, Wanji S, Amazigo UV.

Int Q Community Health Educ. 2012-2013;33(2):159-73. doi: 10.2190/IQ.33.2.e.

PMID:
23661417
16.
17.
18.

Onchocerciasis in Anambra State, Southeast Nigeria: clinical and psychological aspects and sustainability of community directed treatment with ivermectin (CDTI).

Mbanefo EC, Eneanya CI, Nwaorgu OC, Oguoma VM, Otiji MO, Ogolo BA.

Postgrad Med J. 2010 Oct;86(1020):573-7. doi: 10.1136/pgmj.2010.100248.

PMID:
20971709
20.

Community-directed treatment of onchocerciasis with ivermectin in Takum, Nigeria.

Akogun OB, Audu Z, Weiss MG, Adelakun AO, Akoh JI, Akogun MK, Remme H, Kale OO.

Trop Med Int Health. 2001 Mar;6(3):232-43.

Supplemental Content

Support Center